HTMwire
Asimily logo

Asimily

Device Security Platforms

HTMwire assessment

Healthcare device security using AI/ML and MITRE ATT&CK analysis to identify, prioritize, and mitigate vulnerabilities across IoMT and OT devices.

Key Features

  • Patented AI/ML vulnerability analysis using MITRE ATT&CK framework
  • Risk Simulator previews risk reduction before taking action
  • Smart Policy Management for network segmentation orchestration with policy simulation
  • Passive device discovery via DPI, protocol decoding, and ML-based traffic analysis
  • Anomaly detection and automated incident response with packet capture

What It Helps You Do

MITRE ATT&CK vulnerability analysis Risk simulation before action Passive discovery Anomaly detection

What Sets Them Apart

Only IoMT security platform with a Risk Simulator that lets you preview the impact of mitigations before applying them — reduces trial-and-error in vulnerability remediation.

How Asimily Uses AI

Uses AI/ML Machine Learning

HTMwire's independent read on the technology — not the vendor's marketing claim.

Patented AI/ML analyzes each vulnerability using MITRE ATT&CK exploit vectors to identify the top 2% riskiest devices. ML-based traffic analysis and protocol decoding provide passive device discovery. Risk Simulator models impact of mitigations before deployment.

  • ML traffic analysis. Uses machine learning on protocol decoding and deep packet inspection for passive device discovery and behavioral anomaly detection.
  • Exploit-mapped prioritization. Maps each vulnerability to MITRE ATT&CK attacker behaviors plus EPSS and KEV data to surface the riskiest devices.

Key Numbers

  • $10M funding round (Nov 2021), led by Ridge Ventures
  • 11th on 2024 Deloitte Technology Fast 500 (cybersecurity, North America)

Integrations

SIEM platforms NAC solutions Firewalls CMMS platforms

Tags

iomt-security vulnerability-management risk-prioritization network-segmentation

Featured In

Trust Signals

Founders
Founded in 2017 by CEO Shankar Somasundaram (IoT security background) with co-founder Hithesh Nama.
Customers
Healthcare delivery organizations achieving 98% NIST compliance
Certifications
Supports HIPAA, SOC 2, ISO 27001, FDA compliance
Investors / Funding
$10M round (2021) led by Ridge Ventures with Engineering Capital, Inventus Capital, and New Leaf Venture Partners; strategic investment from MemorialCare Innovation Fund.

Frequently Asked Questions

How does Asimily prioritize which device vulnerabilities to fix first?

Asimily's proprietary Vulnerability Prioritization methodology maps each vulnerability to real-world attacker behaviors using the MITRE ATT&CK framework, then factors in CISA KEV, EPSS, device criticality, lateral movement potential, and segmentation to produce a stack-ranked list of the riskiest devices.

Can Asimily model the impact of a fix before deploying it?

Yes. Asimily's Risk Simulator lets teams preview how much risk a mitigation will reduce before applying it, reducing trial-and-error in IoMT vulnerability remediation.

Who founded and funds Asimily?

Asimily was founded in 2017 by CEO Shankar Somasundaram with co-founder Hithesh Nama. It raised a $10M round in November 2021 led by Ridge Ventures, and later took a strategic investment from the MemorialCare Innovation Fund.

Is Asimily growing?

Yes. Asimily was ranked 11th-fastest-growing cybersecurity company in North America on the 2024 Deloitte Technology Fast 500 and has appeared on the Inc. 5000, reflecting rising customer and device-protection volume, though it does not publish a specific device count.

Sources

  1. Businesswire: Asimily raises $10M (Ridge Ventures lead)
  2. Asimily: Vulnerability prioritization mapped to MITRE ATT&CK
  3. MemorialCare Innovation Fund: Asimily on 2024 Deloitte Fast 500

We cite a primary or named source for every claim on this page. How we evaluate →

Last updated: June 9, 2026